Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
J Immunol (1995) 154 (2): 762–771.
Currently there are no citedby results. Try again later.
